[시장보고서]ELISA 검사 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 방법별, 용도별, 기술별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

ELISA 검사 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 방법별, 용도별, 기술별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

ELISA Test Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Method, By Application, By Technology, By End User, By Region and Competition, 2020-2030F

상품코드 : 1878851

리서치사 : TechSci Research

발행일 : 2025년 11월

페이지 정보 : 영문 185 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,681,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500

￦ 8,165,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000

￦ 11,877,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 ELISA 검사 시장은 2024년에 24억 9,000만 달러라고 평가되어 있으며, 2030년까지 CAGR 7.84%로 성장하여 39억 2,000만 달러에 달할 것으로 예측됩니다.

효소면역측정법(ELISA)은 주로 생물학적 시료에서 펩타이드, 단백질, 항체, 호르몬 등의 가용성 물질을 검출 및 정량하기 위해 사용되는 생화학적 방법입니다. 전 세계 ELISA 검사 시장의 확대는 HIV 및 각종 암과 같은 감염성 질환과 만성질환의 유병률 증가로 인해 정확하고 신속한 진단 도구가 필요한 것이 큰 요인으로 작용하고 있습니다. 또한, ELISA 분석의 민감도, 특이성, 자동화를 향상시키는 진단 기술의 지속적인 발전도 시장 성장에 크게 기여하고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	24억 9,000만 달러
시장 규모 : 2030년	39억 2,000만 달러
CAGR : 2025-2030년	7.84%
가장 빠르게 성장하는 부문	샌드위치 ELISA
최대 시장	북미

주요 시장 촉진요인

주요 시장 과제

주요 시장 동향

시장 규모 및 예측
- 금액별
시장 점유율과 예측
- 방법별(직접 ELISA, 간접 ELISA, 샌드위치 ELISA, 경쟁 ELISA)
- 용도별(백신 개발, 면역학, 진단, 독성학, 약물 모니터링 및 제약 산업, 이식, 기타)
- 기술별(화학발광법, 비색법, 형광법)
- 최종사용자별(병원, 진단 센터, 연구소, 기타)
- 지역별
- 기업별(2024)
시장 맵

제6장 북미의 ELISA 검사 시장 전망

시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
- 미국
- 캐나다
- 멕시코

제7장 유럽의 ELISA 검사 시장 전망

시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인

제8장 아시아태평양의 ELISA 검사 시장 전망

시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
- 중국
- 인도
- 일본
- 한국
- 호주

제9장 중동 및 아프리카의 ELISA 검사 시장 전망

시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
- 사우디아라비아
- 아랍에미리트
- 남아프리카공화국

제10장 남미의 ELISA 검사 시장 전망

시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
- 브라질
- 콜롬비아
- 아르헨티나

제11장 시장 역학

성장 촉진요인
과제

제12장 시장 동향과 발전

인수합병
제품 출시
최근 동향

제13장 세계의 ELISA 검사 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협

제15장 경쟁 구도

F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
bioMerieux India Private Limited
Enzo Biochem Inc.
BioLegend, Inc.
ELISA Technologies, Inc.
RayBiotech, Inc.
Eurofins Scientific(Ireland) Limited

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

KSM

영문 목차

영문목차

The Global ELISA Test Market, valued at USD 2.49 Billion in 2024, is projected to experience a CAGR of 7.84% to reach USD 3.92 Billion by 2030. The Enzyme-Linked Immunosorbent Assay (ELISA) is a biochemical technique primarily employed for detecting and quantifying soluble substances such as peptides, proteins, antibodies, and hormones in biological samples. The global ELISA test market's expansion is significantly driven by the escalating prevalence of infectious and chronic diseases, including conditions like HIV and various cancers, which necessitate accurate and timely diagnostic tools. Furthermore, continuous advancements in diagnostic technology, enhancing the sensitivity, specificity, and automation of ELISA assays, contribute substantially to market growth.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 2.49 Billion
Market Size 2030	USD 3.92 Billion
CAGR 2025-2030	7.84%
Fastest Growing Segment	Sandwich ELISA
Largest Market	North America

Key Market Drivers

The global ELISA Test Market is significantly shaped by the escalating prevalence of infectious and chronic diseases, driving a persistent need for accurate and timely diagnostic solutions. The burden of such conditions necessitates widespread testing, with ELISA assays playing a crucial role in disease surveillance and management. For instance, according to the World Health Organization, as of 30 April 2024, over 7.6 million dengue cases were reported globally in 2024, demonstrating the continuous demand for effective diagnostic tools to monitor and control infectious disease outbreaks. This growing disease landscape directly increases the volume of diagnostic procedures required, thereby expanding the market for ELISA tests globally.

Key Market Challenges

High initial investment costs for advanced ELISA equipment and reagents represent a significant challenging factor in the global ELISA test market. The substantial capital expenditure required for acquiring and maintaining sophisticated ELISA systems can limit the adoption of these diagnostic tools, particularly in healthcare settings with restricted budgets. This directly impedes market growth by creating a barrier to entry for smaller laboratories and those in developing regions. For instance, according to a 2024 Lab Manager Industry and Equipment Trends Survey, 55 percent of respondents cited investment in tools, equipment, and instruments as a top challenge, with 64 percent noting difficulty in securing budget approval for new technology. These financial constraints often force laboratories to extend the lifespan of older, less efficient equipment or forgo advanced automation, impacting their capacity for high-throughput testing and the adoption of newer, more sensitive ELISA assays.

Key Market Trends

Miniaturization and Point-of-Care ELISA Platforms are significantly transforming the global ELISA test market by expanding diagnostic accessibility and speeding up result delivery in various settings. This trend facilitates testing closer to patients, moving beyond traditional centralized laboratories and enabling more immediate clinical decisions. The American Association for Clinical Chemistry (AACC) notably underscored the growing importance of decentralized diagnostic solutions by featuring point-of-care as a key topic at its 2023 Annual Scientific Meeting, encompassing a range of cutting-edge diagnostic tests. This strategic shift responds to the demand for rapid, on-site diagnostics that improve patient management, particularly for conditions requiring frequent monitoring or swift intervention. Abbott, a leading diagnostics company, demonstrated advancements in its point-of-care portfolio, with its second-quarter 2024 results highlighting strong demand for rapid diagnostics used for respiratory diseases, often utilizing compact, near-patient platforms. These advancements are critical for the broader adoption of ELISA technologies in diverse healthcare environments.

Key Market Players

F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
bioMerieux India Private Limited
Enzo Biochem Inc.
BioLegend, Inc.
ELISA Technologies, Inc.
RayBiotech, Inc.
Eurofins Scientific (Ireland) Limited

Report Scope:

In this report, the Global ELISA Test Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

ELISA Test Market, By Method:

Direct ELISA
Indirect ELISA
Sandwich ELISA
Competitive ELISA

ELISA Test Market, By Application:

Vaccine Development
Immunology
Diagnostics
Toxicology
Drug Monitoring and Pharmaceutical Industry
Transplantation
Others

ELISA Test Market, By Technology:

Chemiluminescent
Colorimetric
Fluorescent

ELISA Test Market, By End User:

Hospitals
Diagnostic Centers
Research Laboratories
Others

ELISA Test Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global ELISA Test Market.

Available Customizations:

Global ELISA Test Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global ELISA Test Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Method (Direct ELISA, Indirect ELISA, Sandwich ELISA, Competitive ELISA)
- 5.2.2. By Application (Vaccine Development, Immunology, Diagnostics, Toxicology, Drug Monitoring and Pharmaceutical Industry, Transplantation, Others)
- 5.2.3. By Technology (Chemiluminescent, Colorimetric, Fluorescent)
- 5.2.4. By End User (Hospitals, Diagnostic Centers, Research Laboratories, Others)
- 5.2.5. By Region
- 5.2.6. By Company (2024)
5.3. Market Map

6. North America ELISA Test Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Method
- 6.2.2. By Application
- 6.2.3. By Technology
- 6.2.4. By End User
- 6.2.5. By Country
6.3. North America: Country Analysis
- 6.3.1. United States ELISA Test Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Method
    - 6.3.1.2.2. By Application
    - 6.3.1.2.3. By Technology
    - 6.3.1.2.4. By End User
- 6.3.2. Canada ELISA Test Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Method
    - 6.3.2.2.2. By Application
    - 6.3.2.2.3. By Technology
    - 6.3.2.2.4. By End User
- 6.3.3. Mexico ELISA Test Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Method
    - 6.3.3.2.2. By Application
    - 6.3.3.2.3. By Technology
    - 6.3.3.2.4. By End User

7. Europe ELISA Test Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Method
- 7.2.2. By Application
- 7.2.3. By Technology
- 7.2.4. By End User
- 7.2.5. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany ELISA Test Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Method
    - 7.3.1.2.2. By Application
    - 7.3.1.2.3. By Technology
    - 7.3.1.2.4. By End User
- 7.3.2. France ELISA Test Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Method
    - 7.3.2.2.2. By Application
    - 7.3.2.2.3. By Technology
    - 7.3.2.2.4. By End User
- 7.3.3. United Kingdom ELISA Test Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Method
    - 7.3.3.2.2. By Application
    - 7.3.3.2.3. By Technology
    - 7.3.3.2.4. By End User
- 7.3.4. Italy ELISA Test Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Method
    - 7.3.4.2.2. By Application
    - 7.3.4.2.3. By Technology
    - 7.3.4.2.4. By End User
- 7.3.5. Spain ELISA Test Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Method
    - 7.3.5.2.2. By Application
    - 7.3.5.2.3. By Technology
    - 7.3.5.2.4. By End User

8. Asia Pacific ELISA Test Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Method
- 8.2.2. By Application
- 8.2.3. By Technology
- 8.2.4. By End User
- 8.2.5. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China ELISA Test Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Method
    - 8.3.1.2.2. By Application
    - 8.3.1.2.3. By Technology
    - 8.3.1.2.4. By End User
- 8.3.2. India ELISA Test Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Method
    - 8.3.2.2.2. By Application
    - 8.3.2.2.3. By Technology
    - 8.3.2.2.4. By End User
- 8.3.3. Japan ELISA Test Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Method
    - 8.3.3.2.2. By Application
    - 8.3.3.2.3. By Technology
    - 8.3.3.2.4. By End User
- 8.3.4. South Korea ELISA Test Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Method
    - 8.3.4.2.2. By Application
    - 8.3.4.2.3. By Technology
    - 8.3.4.2.4. By End User
- 8.3.5. Australia ELISA Test Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Method
    - 8.3.5.2.2. By Application
    - 8.3.5.2.3. By Technology
    - 8.3.5.2.4. By End User

9. Middle East & Africa ELISA Test Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Method
- 9.2.2. By Application
- 9.2.3. By Technology
- 9.2.4. By End User
- 9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia ELISA Test Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Method
    - 9.3.1.2.2. By Application
    - 9.3.1.2.3. By Technology
    - 9.3.1.2.4. By End User
- 9.3.2. UAE ELISA Test Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Method
    - 9.3.2.2.2. By Application
    - 9.3.2.2.3. By Technology
    - 9.3.2.2.4. By End User
- 9.3.3. South Africa ELISA Test Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Method
    - 9.3.3.2.2. By Application
    - 9.3.3.2.3. By Technology
    - 9.3.3.2.4. By End User

10. South America ELISA Test Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Method
- 10.2.2. By Application
- 10.2.3. By Technology
- 10.2.4. By End User
- 10.2.5. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil ELISA Test Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Method
    - 10.3.1.2.2. By Application
    - 10.3.1.2.3. By Technology
    - 10.3.1.2.4. By End User
- 10.3.2. Colombia ELISA Test Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Method
    - 10.3.2.2.2. By Application
    - 10.3.2.2.3. By Technology
    - 10.3.2.2.4. By End User
- 10.3.3. Argentina ELISA Test Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Method
    - 10.3.3.2.2. By Application
    - 10.3.3.2.3. By Technology
    - 10.3.3.2.4. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global ELISA Test Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. F. Hoffmann-La Roche Ltd.
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Thermo Fisher Scientific, Inc.
15.3. Becton, Dickinson and Company
15.4. Bio-Rad Laboratories, Inc.
15.5. bioMerieux India Private Limited
15.6. Enzo Biochem Inc.
15.7. BioLegend, Inc.
15.8. ELISA Technologies, Inc.
15.9. RayBiotech, Inc.
15.10. Eurofins Scientific (Ireland) Limited